Giulia Quaresmini

Bergamo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy.

Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy.

Journal: Hematological oncology

Published: December 17, 2025

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation.

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation.

Journal: British journal of haematology

Published: October 08, 2024

Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial.

Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Oncology

Published: April 25, 2024

Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study.

Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study.

Journal: Leukemia research

Published: March 28, 2024

Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL.

Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL.

Journal: Blood cancer journal

Published: February 24, 2024

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Journal: American journal of hematology

Published: June 25, 2023

Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.

Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.

Journal: Hematological oncology

Published: April 07, 2023

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.

Journal: Journal of hematology & oncology

Published: April 19, 2022

How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia.

How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma

Published: March 28, 2022

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Journal: Leukemia

Published: July 28, 2021

Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.

Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.

Journal: Hematological oncology

Published: July 14, 2021

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.

Journal: Leukemia

Published: June 13, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026